Warming effect on miriplatin-lipiodol suspension as a chemotherapeutic agent for transarterial chemoembolization for hepatocellular carcinoma: Preliminary clinical experience

CardioVascular and Interventional Radiology

Volumn 36, Issue 4, 2013, Pages 1023-1029

  Kora, Shinn Ichi ^a   Urakawa, Hiroshi ^a   Mitsufuji, Toshimichi ^a   Osame, Akinobu ^a   Higashihara, Hideyuki ^b   Yoshimitsu, Kengo ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b Fukuoka University Chikushi Hospital   (Japan)

Author keywords

Chemoembolization; Hepatocellular carcinoma; Miriplatin; Warming

Indexed keywords

C REACTIVE PROTEIN; GELATIN SPONGE; IODINATED POPPYSEED OIL; IOHEXOL; IOMEPROL; IOPAMIDOL; MIRIPLATIN;

AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LIVER ARTERIOGRAPHY; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ROOM TEMPERATURE; THERAPY EFFECT; TREATMENT RESPONSE; WARMING;

AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COHORT STUDIES; DISEASE-FREE SURVIVAL; ETHIODIZED OIL; FEMALE; HOT TEMPERATURE; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; SUSPENSIONS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84879993184     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-012-0537-3     Document Type: Article

References (14)

1. Kokudo N, Makuuchi M (2009) Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines. J Gastroenterol 44(Suppl 19):119-121
2. Arii S, Sata M, Sakamoto M, Shimada M et al (2010) Management of hepatocellular carcinoma: report of consensus meeting in the 45th annual meeting of the japan society of hepatology (2009). Hepatol Res 40:667-685
3. Hanada M, Baba A, Tsutsumishita Y et al (2009) Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis. Cancer Chemother Pharmacol 64:473-483
4. Hanada M, Baba A, Tsutsumishita Y et al (2009) Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of human hepatoma cells orthotopically implanted in nude rats. Cancer Sci 100:189-194
5. Kora S, Mitsufuji T, Urakawa H et al (2012) Warmed Miriplatin-Lipiodol suspension as a chemotherapeutic agent for hepatocellular carcinoma: phantom study and preliminary clinical results (abstract LL-VIS-WE4C). In: Presented at RSNA 2012, Chicago
6. Miyayama S, Yamashiro M, Shibata Y et al (2012) Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma. Jpn J Radiol 30:263-270
7. Tearayama N, Matsui O, Gabata T et al (2001) Accumulation of iodized oil within the non-neoplastic liver adjacent to hepatocellular carcinoma via the drainage routes of the tumor after transcatheter arterial embolization. Cardiovasc Interv Radiol 24:383-387
8. Miyayama S, Matsui O, Yamamoto Y et al (2007) Ultraselective transcatheter arterial chemoembolization with a 2-Fr tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil. J Vasc Interv Radiol 18:365-376
9. Ueda K, Matsui O, Kawamori Y et al (1998) Hypervascular hepatocellular carcinoma: evaluation of hemodynamics with dynamic CT during hepatic arteriography. Radiology 206:161-166
10. Matsuo N, Uchida H, Sakaguchi H et al (1997) Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings. Semin Oncol 24:S661-S670
11. Higashihara H, Okazaki M (2002) Transcatheter arterial embolization of hepatocellular carcinoma: a Japanese experience. Hepatogastroenterology 49:72-78
12. Liver Cancer Study Group of Japan (2010) General rules for the clinical and pathological study of primary liver cancer, 3rd English edn. Kanehara Co., Ltd., Tokyo
13. Pugacheva O, Matsui O, Kozaka K et al (2011) Detection of small hypervascular hepatocellular carcinomas by EASL criteria: comparison with double-phase CT during hepatic arteriography. Eur J Radiol 80:e201-e206
14. Galloti A, Uggeri F, Favilla A, Cabrini M, de Haen C (1994) The chemistry of iomeprol and physico-chemical properties of its aqueous solutions and pharmaceutical formulations. Eur J Radiol 18(suppl l):S1-S12